Found: 33
Select item for more details and to access through your institution.
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 7, p. 1433, doi. 10.1515/cclm-2023-1448
- By:
- Publication type:
- Article
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay.
- Published in:
- Diagnosis (2194-802X), 2024, v. 11, n. 2, p. 200, doi. 10.1515/dx-2023-0182
- By:
- Publication type:
- Article
Effect of syringe underfilling on the quality of venous blood gas analysis.
- Published in:
- Diagnosis (2194-802X), 2024, v. 11, n. 1, p. 91, doi. 10.1515/dx-2023-0096
- By:
- Publication type:
- Article
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2023, v. 4, n. 4, p. 431, doi. 10.1515/almed-2023-0114
- By:
- Publication type:
- Article
Uso de una tira reactiva paraorina en la evaluación de las concentraciones de glucosa y bilirrubina en plasma en entornos con recursos limitados: un estudio de prueba de concepto.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2023, v. 4, n. 4, p. 435, doi. 10.1515/almed-2023-0153
- By:
- Publication type:
- Article
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration.
- Published in:
- Infectious Diseases Research, 2023, v. 4, n. 4, p. 1, doi. 10.53388/IDR2023018
- By:
- Publication type:
- Article
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Niveles séricos de antígeno prostático específico (PSA) tras vacunación primaria con BNT162b2.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2023, v. 4, n. 3, p. 334, doi. 10.1515/almed-2023-0120
- By:
- Publication type:
- Article
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 9, p. e168, doi. 10.1515/cclm-2023-0164
- By:
- Publication type:
- Article
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 9, p. e172, doi. 10.1515/cclm-2023-0226
- By:
- Publication type:
- Article
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection.
- Published in:
- Diagnosis (2194-802X), 2023, v. 10, n. 3, p. 326, doi. 10.1515/dx-2023-0014
- By:
- Publication type:
- Article
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 8, p. 1506, doi. 10.1515/cclm-2023-0181
- By:
- Publication type:
- Article
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2023, v. 4, n. 2, p. 175, doi. 10.1515/almed-2023-0008
- By:
- Publication type:
- Article
¿Son los anticuerpos IgG e IgM contra los antígenos S y N del SARS-CoV-2 siempre predictores de infección previa por SARS-CoV-2?
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2023, v. 4, n. 2, p. 180, doi. 10.1515/almed-2023-0036
- By:
- Publication type:
- Article
Impact of the COVID-19 pandemic on the volume of laboratory testing.
- Published in:
- Biochimica Clinica, 2023, v. 47, n. 2, p. 171, doi. 10.19186/BC_2023.015
- By:
- Publication type:
- Article
Gammopatia monoclonale e infezione da SARS-CoV-2.
- Published in:
- Biochimica Clinica, 2023, v. 47, n. 2, p. e17, doi. 10.19186/BC_2023.026
- By:
- Publication type:
- Article
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 7, p. 1343, doi. 10.1515/cclm-2023-0055
- By:
- Publication type:
- Article
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test.
- Published in:
- Diagnosis (2194-802X), 2023, v. 10, n. 2, p. 187, doi. 10.1515/dx-2022-0138
- By:
- Publication type:
- Article
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 2, p. 316, doi. 10.1515/cclm-2022-0873
- By:
- Publication type:
- Article
ASSOCIATION BETWEEN VIRAL LOAD AND POSITIVIZATION TIME OF A SARS-COV-2 RAPID ANTIGEN TEST IN ROUTINE NASOPHARYNGEAL SPECIMENS.
- Published in:
- Journal of Medical Biochemistry, 2022, v. 41, n. 4, p. 513, doi. 10.5937/jomb0-35482
- By:
- Publication type:
- Article
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 8, p. e181, doi. 10.1515/cclm-2022-0385
- By:
- Publication type:
- Article
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2022, v. 3, n. 2, p. 167, doi. 10.1515/almed-2022-0033
- By:
- Publication type:
- Article
Impacto de la vacunación primaria con BNT162b2 y una dosis de refuerzo homóloga en los anticuerpos IgA contra SARS-CoV-2 en profesionales sanitarios seronegativos.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2022, v. 3, n. 2, p. 171, doi. 10.1515/almed-2022-0051
- By:
- Publication type:
- Article
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 6, p. 930, doi. 10.1515/cclm-2022-0212
- By:
- Publication type:
- Article
TOTAL ANTI-SARS-COV-2 ANTIBODIES MEASURED 6 MONTHS AFTER PFIZER-BIONTECH COVID-19 VACCINATION IN HEALTHCARE WORKERS.
- Published in:
- Journal of Medical Biochemistry, 2022, v. 41, n. 2, p. 199, doi. 10.5937/jomb0-33999
- By:
- Publication type:
- Article
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals.
- Published in:
- 2022
- By:
- Publication type:
- Letter
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters.
- Published in:
- 2022
- By:
- Publication type:
- Letter
ANTI-SPIKE S1 IGA, ANTI-SPIKE TRIMERIC IGG, AND ANTI-SPIKE RBD IGG RESPONSE AFTER BNT162B2 COVID-19 MRNA VACCINATION IN HEALTHCARE WORKERS.
- Published in:
- Journal of Medical Biochemistry, 2021, v. 40, n. 4, p. 327, doi. 10.5937/jomb0-32373
- By:
- Publication type:
- Article
COMPARISON OF FIVE COMMERCIAL ANTI-SARS-COV-2 TOTAL ANTIBODIES AND IgG IMMUNOASSAYS AFTER VACCINATION WITH BNT162B2 MRNA.
- Published in:
- Journal of Medical Biochemistry, 2021, v. 40, n. 4, p. 335, doi. 10.5937/jomb0-31475
- By:
- Publication type:
- Article
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 9, p. 1585, doi. 10.1515/cclm-2021-0339
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 5, p. 832, doi. 10.3390/diagnostics11050832
- By:
- Publication type:
- Article